Comparison of asymptomatic bacteriuria escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes

Infection and Immunity

Volumn 80, Issue 2, 2012, Pages 668-678

  Salvador, Ellaine ^a   Wagenlehner, Florian ^b   Köhler, Christian Daniel ^a,c   Mellmann, Alexander ^c   Hacker, Jörg ^d   Svanborg, Catharina ^e   Dobrindt, Ulrich ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d German Academy of Sciences Leopoldina   (Germany)

^e LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; AEROBACTIN; YERSINIABACTIN;

ADULT; AGED; ARTICLE; ASYMPTOMATIC BACTERIURIA; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BLADDER CATHETERIZATION; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FIMBRIA; GENE DELETION; HOSPITAL PATIENT; HUMAN; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTPATIENT; PHYLOGENY; POINT MUTATION; PRIORITY JOURNAL; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

BACTERIAL PROTEINS; BACTERIURIA; CHILD; CLUSTER ANALYSIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HOSPITALIZATION; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; SELECTION, GENETIC; TIME FACTORS; URINARY BLADDER; VIRULENCE;

EID: 84857165872     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06191-11     Document Type: Article

References (67)

1. Agace WW, Hedges SR, Ceska M, Svanborg C. 1993. Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J. Clin. Invest. 92:780-785.
2. Altschul SF, et al. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
3. Andersson P, et al. 1991. Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect. Immun. 59:2915-2921.
4. Bergsten G, et al. 2004. PapG-dependent adherence breaks mucosal inertia and triggers the innate host response. J. Infect. Dis. 189:1734-1742.
5. Bergsten G, Wullt B, Svanborg C. 2005. Escherichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract. Int. J. Med. Microbiol. 295:487-502.
6. Bettelheim KA, Taylor J. 1969. A study of Escherichia coli isolated from chronic urinary infection. J. Med. Microbiol. 2:225-236.
7. Braun V, Gross R, Köster W, Zimmermann L. 1983. Plasmid and chromosomal mutants in the iron(III)-aerobactin transport system of Escherichia coli. Use of streptonigrin for selection. Mol. Gen. Genet. 192: 131-139.
8. Chromek M, et al. 2006. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12:636-641.
9. de Hoon MJ, Imoto S, Nolan J, Miyano S. 2004. Open source clustering software. Bioinformatics 20:1453-1454.
10. Didelot X, Falush D. 2007. Inference of bacterial microevolution using multilocus sequence data. Genetics 175:1251-1266.
11. Dobrindt U, et al. 2003. Analysis of genome plasticity in pathogenic and commensal Escherichia coli isolates by use of DNA arrays. J. Bacteriol. 185:1831-1840.
12. Edén CS, et al. 1978. Adhesion to normal human uroepithelial cells of Escherichia coli from children with various forms of urinary tract infection. J. Pediatr. 93:398-403.
13. Edén CS, Hanson LA, Jodal U, Lindberg U, Akerlund AS. 1976. Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet i:490-492.
14. Edén CS, Janson GL, Lindberg U. 1979. Adhesiveness to urinary tract epithelial cells of fecal and urinary Escherichia coli isolates from patients with symptomatic urinary tract infections or asymptomatic bacteriuria of varying duration. J. Urol. 122:185-188.
15. Falush D, Stephens M, Pritchard JK. 2003. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 164:1567-1587.
16. Falush D, et al. 2003. Traces of human migrations in Helicobacter pylori populations. Science 299:1582-1585.
17. Fischer H, et al. 2010. Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection. PLoS Pathog. 6:e1001109.
18. Fünfstück R, et al. 1986. Virulence properties of Escherichia coli strains in patients with chronic pyelonephritis. Infection 14:145-150.
19. Graham JC, et al. 2001. Analysis of Escherichia coli strains causing bacteriuria during pregnancy: selection for strains that do not express type 1 fimbriae. Infect. Immun. 69:794-799.
20. Grönberg-Hernández J, Sundén F, Connolly J, Svanborg C, Wullt B. 2011. Genetic control of the variable innate immune response to asymptomatic bacteriuria. PLoS One 6:e28289.
21. Hagberg L, Briles DE, Eden CS. 1985. Evidence for separate genetic defects in C3H/HeJ and C3HeB/FeJ mice, that affect susceptibility to gram-negative infections. J. Immunol. 134:4118-4122.
22. Hagberg L, et al. 1984. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect. Immun. 46:839-844.
23. Hogardt M, Heesemann J. 2010. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int. J. Med. Microbiol. 300: 557-562.
24. Horan TC, Andrus M, Dudeck MA. 2008. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 36:309-332.
25. Hull RA, Rudy DC, Wieser IE, Donovan WH. 1998. Virulence factors of Escherichia coli isolates from patients with symptomatic and asymptomatic bacteriuria and neuropathic bladders due to spinal cord and brain injuries. J. Clin. Microbiol. 36:115-117.
26. Jelsbak L, et al. 2007. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect. Immun. 75:2214-2224.
27. Johnson JR, Stell AL. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181:261-272.
28. Klemm P, Roos V, Ulett GC, Svanborg C, Schembri MA. 2006. Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect. Immun. 74:781-785.
29. Krieger JN, Kaiser DL, Wenzel RP. 1983. Nosocomial urinary tract infections: secular trends, treatment and economics in a university hospital. J. Urol. 130:102-106.
30. Kunin CM. 1997. Urinary tract infections. Detection, prevention and management, 5th ed. The Williams & Wilkins Co., Baltimore, MD.
31. Larkin MA, et al. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948.
32. Leffler H, et al. 1995. Strategies for studying bacterial adhesion in vivo. Methods Enzymol. 253:206-220.
33. Lindberg U, Claesson I, Hanson LA, Jodal U. 1978. Asymptomatic bacteriuria in schoolgirls. VIII. Clinical course during a 3-year follow-up. J. Pediatr. 92:194-199.
34. Mabbett AN, et al. 2009. Virulence properties of asymptomatic bacteriuria Escherichia coli. Int. J. Med. Microbiol. 299:53-63.
35. Nicolle LE, et al. 2005. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin. Infect. Dis. 40:643-654.
36. Nielubowicz GR, Mobley HL. 2010. Host-pathogen interactions in urinary tract infection. Nat. Rev. Urol. 7:430-441.
37. Nordenstam G, Sundh V, Lincoln K, Svanborg A, Eden CS. 1989. Bacteriuria in representative population samples of persons aged 72-79 years. Am. J. Epidemiol. 130:1176-1186.
38. Oh JD, et al. 2006. The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression. Proc. Natl. Acad. Sci. U. S. A. 103:9999-10004.
39. Olesen B, Kolmos HJ, Orskov F, Orskov I. 1998. Escherichia coli bacteraemia in patients with and without haematological malignancies: a study of strain characters and recurrent episodes. J. Infect. 36:93-100.
40. Plos K, et al. 1995. Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. J. Infect. Dis. 171:625-631.
41. Plowman R, et al. 1999. The socio-economic burden of healthcare associated infection. Public Health Laboratory Service, London, United Kingdom.
42. Pritchard JK, Stephens M, Donnelly P. 2000. Inference of population structure using multilocus genotype data. Genetics 155:945-959.
43. Ragnarsdottir B, et al. 2008. TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections. Eur. J. Clin. Invest. 38(Suppl 2):12-20.
44. Ragnarsdottir B, et al. 2010. Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PLoS One 5:e10734.
45. Ragnarsdottir B, Lutay N, Gronberg-Hernandez J, Koves B, Svanborg C. 2011. Genetics of innate immunity and UTI susceptibility. Nat. Rev. Urol. 8:449-468.
46. Ragnarsdottir B, et al. 2007. Reduced Toll-like receptor 4 expression in children with asymptomatic bacteriuria. J. Infect. Dis. 196:475-484.
47. Raz R. 2003. Asymptomatic bacteriuria. Clinical significance and management. Int. J. Antimicrob. Agents 22(Suppl 2):45-47.
48. Roos V, Nielsen EM, Klemm P. 2006. Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. FEMS Microbiol. Lett. 262:22-30.
49. Roos V, Schembri MA, Ulett GC, Klemm P. 2006. Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae. Microbiology 152:1799-1806.
50. Saitou N, Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
51. Saldanha AJ. 2004. Java Treeview-extensible visualization of microarray data. Bioinformatics 20:3246-3248.
52. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
53. Smith EE, et al. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 103: 8487-8492.
54. Sunden F, Hakansson L, Ljunggren E, Wullt B. 2010. Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying. J. Urol. 184:179-185.
55. Takahashi A, et al. 2006. Escherichia coli isolates associated with uncomplicated and complicated cystitis and asymptomatic bacteriuria possess similar phylogenies, virulence genes, and O-serogroup profiles. J. Clin. Microbiol. 44:4589-4592.
56. Tamura K, et al. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739.
57. Turck M, Stamm W. 1981. Nosocomial infection of the urinary tract. Am. J. Med. 70:651-654.
58. Wagenlehner FM, et al. 2002. Epidemiological analysis of the spread of pathogens from a urological ward using genotypic, phenotypic and clinical parameters. Int. J. Antimicrob. Agents 19:583-591.
59. Wagenlehner FM, Niemetz AH, Weidner W, Naber KG. 2008. Spectrum and antibiotic resistance of uropathogens from hospitalised patients with urinary tract infections: 1994-2005. Int. J. Antimicrob. Agents 31(Suppl. 1):S25-S34.
60. Warren JW. 1997. Catheter-associated urinary tract infections. Infect. Dis. Clin. North Am. 11:609-622.
61. Watts RE, et al. 2010. Escherichia coli isolates causing asymptomatic bacteriuria in catheterized and noncatheterized individuals possess similar virulence properties. J. Clin. Microbiol. 48:2449-2458.
62. Wiles TJ, Kulesus RR, Mulvey MA. 2008. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85: 11-19.
63. Wirth T, et al. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol. Microbiol. 60:1136-1151.
64. Wullt B, et al. 1998. Urodynamic factors influence the duration of Escherichia coli bacteriuria in deliberately colonized cases. J. Urol. 159:2057-2062.
65. Zdziarski J, et al. 2010. Host imprints on bacterial genomes-rapid, divergent evolution in individual patients. PLoS Pathog. 6:e1001078.
66. Zdziarski J, Svanborg C, Wullt B, Hacker J, Dobrindt U. 2008. Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation? Infect. Immun. 76:695-703.
67. Zuckerkandl E, Pauling L. 1965. Molecules as documents of evolutionary history. J. Theor. Biol. 8:357-366.